Related Experiment Video
Updated: Jun 21, 2026
09:34
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
Published on: November 27, 2017
Human parthenogenetic embryonic stem cells: one potential resource for cell therapy.
Jie Hao1, WanWan Zhu, Chao Sheng
1State Key Laboratory of Reproductive Biology, Institute of Zoology, Beijing, 100101, China.
Science in China. Series C, Life Sciences
|July 31, 2009
Summary
Parthenogenetic embryonic stem cells (hPG ESCs) offer a promising alternative for cell therapies due to their histocompatibility. Further research is needed to confirm their full differentiation potential for clinical applications.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Reproductive biology
Background:
- Somatic cell reprogramming (nuclear transfer, induced pluripotent stem cells) offers research models and therapeutic potential.
- Limitations include low efficiency and safety concerns for current reprogramming methods.
- Parthenogenetic embryonic stem cells (hPG ESCs) present an alternative source of histocompatible cells.
Purpose of the Study:
- To evaluate human parthenogenetic embryonic stem cells (hPG ESCs) as a source for cell therapy.
- To compare hPG ESCs with human embryonic stem cells (hESCs) from other sources.
- To investigate the differentiation and developmental potential of hPG ESCs for clinical applications.
Main Methods:
- Generation of hPG ESCs from parthenogenetic embryos.
- Characterization of hPG ESCs, including gene expression analysis.
- Assessment of differentiation and developmental potential (further investigation required).
Main Results:
- hPG ESCs exhibit similarities to hESCs derived from IVF or in vivo blastocysts in gene expression and characteristics.
- The full differentiation and developmental potential of hPG ESCs requires further investigation.
Conclusions:
- hPG ESCs are a viable alternative for generating histocompatible cells for regenerative medicine.
- Further research is crucial to fully understand and validate the therapeutic potential of hPG ESCs before clinical translation.
- Advancements in reprogramming techniques will enhance understanding of stem cell biology and benefit cell therapy.
More Related Videos
09:00Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
Published on: June 16, 2019
10:47Efficient Derivation of Human Neuronal Progenitors and Neurons from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: October 28, 2011
Related Concept Videos
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...